Nephros, Inc. (NEPH)

5.20 +0.54 (+11.59%) USD  |  NASDAQ  |  Dec 24, 12:59
5.20 0.00 (0.00%) After-Hours: 13:59
More

Nephros SG&A Expense (TTM): 8.556M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NEPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Apyx Medical Corp. 22.16M
Owlet, Inc. 49.64M
Perspective Therapeutics, Inc. 31.53M
Xtant Medical Holdings, Inc. 74.03M
VolitionRX Ltd. 13.97M